Data search


search
Exact
Search

Results for MligTC455_40075

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_40075 72 1.50 Mlig455_003636, Mlig455_003841

Neo: -

Age: -

Mlig455_003636 {REF} {Length: 1017} {Pfam: PAN domain [PF00024.28, score=20.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=69.7, Expect=2e-14]} {RNA1310_45613} {RNA815_17816.1}

Mlig455_003841 {REF} {Length: 978} {TRANSSPLICED} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=70.5, Expect=1e-14]} {RNA1310_45613} {RNA815_17816.1}

Cumulative graph for MligTC455_40075

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -3.332 1.491 0.99967 1.00000
RegionR2 2.03 1.491 0.21636 0.58317
RegionR3 1.119 1.491 0.39867 0.92805
RegionR4 2.754 1.491 0.11773 0.34298
RegionR5 -0.309 1.491 0.90597 1.00000
RegionR6 -1.327 1.491 0.97983 1.00000
RegionR7 1.844 1.491 0.27404 0.90493
RegionR8 -2.779 1.491 0.99951 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -0.026 1.491 1.00000 1.00000
RegenerationR2 0.977 1.491 0.45918 0.85202
RegenerationR3 0.389 1.491 0.83332 0.99165
RegenerationR4 -0.904 1.491 0.55587 0.89497
RegenerationR5 1.425 1.491 0.33221 0.75302
RegenerationR6 1.753 1.491 0.37990 0.72144
RegenerationBL 0.73 1.491 0.66019 0.99497
RegenerationTP 2.655 1.491 0.27578 0.72339


Genes with expression patterns similar to MligTC455_40075

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_40075 72 1.5 Mlig455_003636, Mlig455_003841

Neo: -

Age: -

5 - 1.000 1.000 1.000 1.000 1.000

Mlig455_003636 {REF} {Length: 1017} {Pfam: PAN domain [PF00024.28, score=20.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=69.7, Expect=2e-14]} {RNA1310_45613} {RNA815_17816.1}

Mlig455_003841 {REF} {Length: 978} {TRANSSPLICED} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=70.5, Expect=1e-14]} {RNA1310_45613} {RNA815_17816.1}
2. MligTC455_18607 203 4.23 Mlig455_012344, Mlig455_012722

Neo: -

Age: -

Region-enriched R2: 3.338/0.02204

ANKRD63 3.602 - 0.826 0.941 - 0.966 0.869

Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436}

Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436}
3. MligTC455_48713 380 7.92 Mlig455_009259, Mlig455_009268

Neo: -

Age: Down-Up-Down

Region-specific R2: 6.962

Region-enriched R2: 4.845/0.00046
Region-enriched R6: 3.343/0.03198

3.469 - 0.844 0.873 - 0.961 0.791

Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404}

Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404}
4. MligTC455_19552 288 6 Mlig455_055936, Mlig455_068188

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.424

Region-specific R2: 6.302

Region-enriched R2: 4.919/0.00633

Regeneration-depleted R4: -5.607
Regeneration-depleted R2: -3.270

3.409 - 0.886 0.818 - 0.989 0.716

Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745}

Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745}
5. MligTC455_52629 472 9.83 Mlig455_059435

Neo: -

Age: Down-Up-Up

Region-specific R2: 6.775

Region-enriched R2: 6.727/0.00002

2.764 - 0.893 0.892 - 0.979 - Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881}
6. MligTC455_47780 214 4.46 Mlig455_018842, Mlig455_018853

Neo: -

Age: -

2.763 - 0.896 0.890 - 0.977 -

Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082}

Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082}
7. MligTC455_48656 24 0.5 Mlig455_039647

Neo: -

Age: -

2.75 - 0.897 0.893 - 0.960 - Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969}
8. MligTC455_22077 58 1.2 Mlig455_041277

Neo: -

Age: -

2.738 - 0.897 0.882 - 0.959 - Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833}
9. MligTC455_12511 68 1.42 Mlig455_017662

Neo: -

Age: -

2.725 - 0.900 0.846 - 0.979 - Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171}
10. MligTC455_33440 62 1.29 Mlig455_053806, Mlig455_053807

Neo: -

Age: Up-Down-Down

Region-enriched R2: 5.142/0.02950

GRID1 2.722 - 0.871 0.874 - 0.977 -

Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458}

Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458}
11. MligTC455_49451 16 0.34 Mlig455_030374

Neo: -

Age: -

NOX5 2.711 - 0.897 0.849 - 0.965 - Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457}
12. MligTC455_12512 80 1.68 Mlig455_017689

Neo: -

Age: -

2.71 - 0.897 0.818 - 0.995 - Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171}
13. MligTC455_43714 152 3.18 Mlig455_000684, Mlig455_000736

Neo: -

Age: -

2.71 - 0.897 0.859 - 0.954 -

Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250}

Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250}
14. MligTC455_45351 241 5.02 Mlig455_031191

Neo: -

Age: Down-Up-Down

Region-enriched R2: 4.622/0.00310

2.694 - 0.884 0.836 - 0.974 - Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062}
15. MligTC455_47420 218 4.54 Mlig455_017159, Mlig455_048110

Neo: -

Age: -

Region-specific R2: 6.469

Region-enriched R2: 5.851/0.00135

2.692 - 0.857 0.867 - 0.968 -

Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586}

Mlig455_048110 {REF} {Length: 527} {RNA1310_81586}
16. MligTC455_10966 15 0.31 Mlig455_013154

Neo: -

Age: -

2.689 - 0.878 0.830 - 0.981 - Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1}
17. MligTC455_39495 30 0.62 Mlig455_037087

Neo: -

Age: -

2.681 - 0.897 0.832 - 0.952 - Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367}
18. MligTC455_43390 28 0.59 Mlig455_064273

Neo: -

Age: Down-Up-Down

PRKAR2A 2.671 - 0.874 0.840 - 0.957 - Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628}
19. MligTC455_51386 763 15.89 Mlig455_041336, Mlig455_056222

Neo: -

Age: -

Region-enriched R2: 3.643/0.00016

HPGDS 2.668 - 0.887 0.817 - 0.964 -

Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778}

Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778}
20. MligTC455_17178 54 1.12 Mlig455_067758

Neo: -

Age: -

Region-enriched R2: 7.471/0.00007

2.663 - 0.826 0.853 - 0.984 - Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1}
21. MligTC455_43715 48 0.99 Mlig455_034191

Neo: -

Age: Down-Up-Down

Region-enriched R2: 7.969/0.00817

2.657 - 0.877 0.817 - 0.963 - Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250}
22. MligTC455_29100 53 1.11 Mlig455_022386, Mlig455_022475

Neo: -

Age: -

Region-enriched R2: 7.567/0.00114
Region-enriched R6: 6.070/0.00443

KREMEN2 2.647 - 0.777 0.870 - 1.000 -

Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500}

Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500}
23. MligTC455_31901 18 0.38 Mlig455_022355

Neo: -

Age: -

2.646 - 0.897 0.798 - 0.951 - Mlig455_022355 {REF} {Length: 541} {Pfam: PAN domain [PF00024.28, score=19.0]} {RNA1310_125793} {RNA815_23776.1}
24. MligTC455_38162 710 14.8 Mlig455_045004

Neo: -

Age: Down-Up-Up

Region-specific R2: 5.269

Region-enriched R2: 5.838/0.00000

Regeneration-downregulated R2: -4.412

Regeneration-depleted R2: -4.412

2.624 - 0.874 0.788 - 0.962 - Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915}
25. MligTC455_50455 972 20.25 Mlig455_070346

Neo: -

Age: -

Region-specific R2: 4.855

Region-enriched R2: 5.186/0.00000

2.61 - 0.873 0.785 - 0.952 - Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071}
26. MligTC455_09510 314 6.55 Mlig455_001134, Mlig455_042048

Neo: -

Age: -

Region-specific R2: 5.291

Region-enriched R2: 5.151/0.00029

2.607 - 0.839 0.793 - 0.975 -

Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1}

Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1}
27. MligTC455_52767 21 0.43 Mlig455_039993

Neo: -

Age: -

Region-enriched R2: 6.584/0.03176

2.601 - 0.866 0.772 - 0.963 - Mlig455_039993 {REF} {Length: 2109} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=23.3]} {RNA1310_67588} {RNA815_46201}
28. MligTC455_12183 53 1.11 Mlig455_004166, Mlig455_004190

Neo: -

Age: -

Region-enriched R2: 4.930/0.01881

2.6 - - 0.847 - 0.981 0.772

Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453}

Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453}
29. MligTC455_12126 26 0.55 Mlig455_040946

Neo: -

Age: -

2.572 - 0.738 0.835 - 0.999 - Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956}
30. MligTC455_51334 326 6.78 Mlig455_011442, Mlig455_061180

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.828

2.566 - 0.767 0.832 - 0.967 -

Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867}

Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867}
31. MligTC455_53546 130 2.72 Mlig455_013326, Mlig455_013334

Neo: -

Age: -

Region-enriched R2: 6.753/0.01892

MMP9 2.562 - 0.859 0.751 - 0.952 -

Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136}

Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136}
32. MligTC455_22428 96 2.01 Mlig455_011005

Neo: -

Age: -

2.556 - - 0.837 - 0.967 0.752 Mlig455_011005 {REF} {Length: 3873} {Pfam: WS/DGAT C-terminal domain [PF06974.15, score=54.7]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=22.2]; Telomere-associated protein TERB2 [PF15101.8, score=20.0]; ZIP Zinc transporter [PF02535.24, score=18.7]; Ureide permease [PF07168.13, score=17.4]} {Smed: dd_Smed_v6_7004_0_1, dd_Smed_v6_7004_0_1, [Score=151, Expect=2e-37]} {RNA1310_98904}
33. MligTC455_11064 54 1.12 Mlig455_004434, Mlig455_004446

Neo: -

Age: -

2.551 - 0.811 0.790 - 0.950 -

Mlig455_004434 {REF} {Length: 532} {TRANSSPLICED} {RNA1310_102702}

Mlig455_004446 {REF} {Length: 617} {TRANSSPLICED} {RNA1310_102702}
34. MligTC455_40406 59 1.23 Mlig455_062481

Neo: -

Age: -

CHRNA9 2.548 - 0.761 0.802 - 0.985 - Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3}
35. MligTC455_37188 31 0.65 Mlig455_000345

Neo: -

Age: -

TRAF5 2.535 - 0.775 0.793 - 0.967 - Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]}
36. MligTC455_47913 139 2.89 Mlig455_025678

Neo: -

Age: Up-Down-Up

Region-enriched R2: 4.279/0.00526
Region-enriched R4: 3.529/0.01391

2.517 - 0.851 0.708 - 0.958 - Mlig455_025678 {REF} {Length: 634} {RNA1310_78201} {RNA815_41088}
37. MligTC455_12545 37 0.76 Mlig455_069121

Neo: -

Age: -

2.492 - 0.770 - - 0.976 0.746 Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125}
38. MligTC455_42256 163 3.39 Mlig455_054046

Neo: -

Age: Down-Up-Up

LDB2 2.492 - - 0.825 - 0.959 0.708 Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302}
39. MligTC455_15927 157 3.26 Mlig455_032763

Neo: -

Age: logFC(26M/2M)=1.700

2.412 - - - 0.731 0.981 0.700 Mlig455_032763 {REF} {Length: 628} {RNA1509_55349} {RNA1310_76770, RNA1509_55349} {RNA1509_55349, RNA815_39882}
40. MligTC455_49285 164 3.41 Mlig455_004486, Mlig455_037380

Neo: -

Age: -

Region-specific R2: 6.095

Region-enriched R2: 5.942/0.00244

LEF1 2.398 - - 0.717 - 0.960 0.721

Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141}

Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141}
41. MligTC455_12180 107 2.23 Mlig455_038554, Mlig455_052202, Mlig455_053449

Neo: -

Age: logFC(26M/2M)=-0.655

Region-enriched R2: 5.717/0.01573

CNGA3 2.397 - 0.710 0.711 - 0.976 -

Mlig455_038554 {REF} {Length: 2866} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=75.9]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=607, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=669, Expect=0.0]} {RNA1310_22950} {RNA815_16119}

Mlig455_052202 {REF} {Length: 3203} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=76.1]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.2]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=605, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=667, Expect=0.0]} {RNA1310_22950} {RNA815_16119}

Mlig455_053449 {REF} {Length: 991} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=79.9]; Cyclic nucleotide-binding domain [PF00027.31, score=29.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=171, Expect=7e-50]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=161, Expect=2e-46]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=155, Expect=4e-44]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=148, Expect=1e-41]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=149, Expect=3e-42]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=155, Expect=8e-45]} {RNA1310_61700} {RNA815_16119}
42. MligTC455_17895 389 8.1 Mlig455_060774

Neo: -

Age: Down-Up-Up, logFC(26M/2M)=0.268

Region-specific R2: 7.424

Region-enriched R2: 6.488/0.00062

Regeneration-downregulated R2: -4.133

Regeneration-depleted R2: -4.133

2.393 - 0.717 - - 0.969 0.707 Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590}
43. MligTC455_49434 157 3.26 Mlig455_068252, Mlig455_068272

Neo: -

Age: -

1.923 - - 0.946 - 0.977 -

Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052}

Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052}
44. MligTC455_53838 10 0.21 Mlig455_008156

Neo: -

Age: -

1.883 - - 0.902 - 0.981 - Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107}
45. MligTC455_16974 15 0.32 Mlig455_052824

Neo: -

Age: -

1.878 - 0.897 - - 0.981 - Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2}
46. MligTC455_36698 41 0.85 Mlig455_020379, Mlig455_020438

Neo: -

Age: -

Region-enriched R4: 4.050/0.03458

1.877 - - 0.913 - 0.964 -

Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935}

Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935}
47. MligTC455_14036 33 0.69 Mlig455_059133

Neo: -

Age: -

Region-enriched R2: 6.942/0.00135

GRIK2 1.872 - - 0.901 - 0.971 - Mlig455_059133 {REF} {Length: 360} {TRANSSPLICED} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.4]; Receptor family ligand binding region [PF01094.30, score=55.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=50.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=31.2]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.6]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=167, Expect=5e-42]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=166, Expect=8e-42]} {Dmel: FBgn0038837, CG3822, [Score=171, Expect=1e-43]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=129, Expect=1e-30]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=273, Expect=6e-84]}
48. MligTC455_45285 7 0.14 Mlig455_046883

Neo: -

Age: -

1.871 - - 0.890 - 0.981 - Mlig455_046883 {REF} {Length: 2303} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]} {Celegans: WBGene00008885, F16C3.1, [RH, Score=57.0, Expect=2e-08]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=80.5, Expect=3e-16]} {RNA1509_24228} {RNA1310_11273}
49. MligTC455_51288 32 0.66 Mlig455_033307

Neo: -

Age: -

NRG2 1.869 - - 0.913 - 0.956 - Mlig455_033307 {REF} {Length: 1876} {TRANSSPLICED} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=62.6]; Immunoglobulin domain [PF13927.8, score=57.8]; Immunoglobulin domain [PF00047.27, score=52.9]; Immunoglobulin domain [PF13895.8, score=42.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=21.9]; Immunoglobulin V-set domain [PF07686.19, score=21.5]} {Human: ENSG00000158458, NRG2, neuregulin 2, [RH, Score=78.6, Expect=9e-15]} {Mouse: ENSMUSG00000060275, Nrg2, neuregulin 2, [Score=79.3, Expect=5e-15]} {Dmel: FBgn0003984, vn, vein, [RH, Score=79.3, Expect=3e-15]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=58.5, Expect=1e-08]} {Smed: dd_Smed_v6_16809_0_1, dd_Smed_v6_16809_0_1, [RH, Score=77.8, Expect=3e-15]} {RNA1310_26045.2} {RNA815_30218}
50. MligTC455_17633 25 0.51 Mlig455_066373

Neo: -

Age: -

RHBG 1.868 - - 0.887 - 0.981 - Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087}
51. MligTC455_41382 65 1.35 Mlig455_022554

Neo: -

Age: -

Region-enriched R2: 5.596/0.01432

1.867 - 0.894 - - 0.973 - Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745}
52. MligTC455_50931 28 0.58 Mlig455_046985, Mlig455_047028

Neo: -

Age: -

FCN2 1.864 - - 0.885 - 0.979 -

Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}

Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}
53. MligTC455_10017 8 0.17 Mlig455_034677

Neo: -

Age: -

GUCY2F 1.862 - - 0.883 - 0.979 - Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185}
54. MligTC455_46445 169 3.51 Mlig455_065678

Neo: -

Age: Down-Down-Up

1.86 - 0.901 - - 0.959 - Mlig455_065678 {REF} {Length: 599} {RNA1509_44880} {RNA1310_1166} {RNA815_18139}
55. MligTC455_15124 25 0.53 Mlig455_017684

Neo: -

Age: -

IGSF9 1.859 - - 0.890 - 0.969 - Mlig455_017684 {REF} {Length: 3509} {Pfam: Immunoglobulin domain [PF13927.8, score=138.2]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=104.0]; Immunoglobulin domain [PF00047.27, score=66.0]; Immunoglobulin V-set domain [PF07686.19, score=56.4]; Fibronectin type III domain [PF00041.23, score=26.9]; Immunoglobulin domain [PF18452.3, score=22.7]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=22.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=19.2]} {Human: ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=128, Expect=2e-29]; ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=124, Expect=3e-28]} {Dmel: FBgn0010473, tutl, turtle, [Score=130, Expect=1e-30]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [Score=94.7, Expect=1e-19]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=120, Expect=2e-27]} {RNA1310_85001}
56. MligTC455_35813 35 0.73 Mlig455_013562, Mlig455_013615

Neo: -

Age: -

Region-enriched R2: 7.733/0.00085

NPR2 1.858 - 0.892 - - 0.966 -

Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869}

Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407}
57. MligTC455_11306 10 0.2 Mlig455_030223

Neo: -

Age: -

ANGPT4 1.857 - - 0.876 - 0.981 - Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322}
58. MligTC455_40388 23 0.47 Mlig455_019615

Neo: -

Age: -

1.857 - - 0.877 - 0.980 - Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562}
59. MligTC455_15949 37 0.76 Mlig455_059880

Neo: -

Age: -

1.856 - - 0.859 - 0.997 - Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903}
60. MligTC455_40617 11 0.22 Mlig455_043552

Neo: -

Age: -

WSCD2 1.856 - - 0.864 - 0.992 - Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]}
61. MligTC455_10786 15 0.32 Mlig455_018164

Neo: -

Age: -

1.855 - - 0.894 - 0.961 - Mlig455_018164 {REF} {Length: 1819} {Pfam: F5/8 type C domain [PF00754.27, score=24.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=57.8, Expect=5e-10]} {RNA1310_114361}
62. MligTC455_12673 10 0.2 Mlig455_003447

Neo: -

Age: -

1.855 - - 0.894 - 0.961 - Mlig455_003447 {REF} {Length: 1947} {RNA1509_51609} {RNA1310_3461} {RNA815_16498}
63. MligTC455_21291 27 0.57 Mlig455_009651

Neo: -

Age: -

1.853 - - 0.891 - 0.962 - Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115}
64. MligTC455_26356 62 1.3 Mlig455_042551

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.548

GRIK2 1.853 - 0.897 - - 0.956 - Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044}
65. MligTC455_26322 65 1.35 Mlig455_042546

Neo: -

Age: -

GRID2 1.851 - 0.873 - - 0.978 - Mlig455_042546 {REF} {Length: 3217} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=49.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=35.5]; Receptor family ligand binding region [PF01094.30, score=33.7]} {Human: ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=127, Expect=3e-29]} {Mouse: ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=129, Expect=5e-30]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=133, Expect=1e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=6e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=238, Expect=8e-71]} {RNA1310_27694} {RNA815_34664}
66. MligTC455_29587 14 0.29 Mlig455_044070

Neo: -

Age: -

1.851 - - 0.857 - 0.994 - Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621}
67. MligTC455_10383 13 0.27 Mlig455_040199

Neo: -

Age: -

1.846 - - 0.872 - 0.974 - Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1}
68. MligTC455_46430 62 1.29 Mlig455_057117, Mlig455_069301

Neo: -

Age: -

GUCY2F 1.846 - - 0.883 - 0.963 -

Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108}

Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181}
69. MligTC455_39064 110 2.28 Mlig455_000222, Mlig455_058480

Neo: Irradiation

Age: -

Region-enriched R2: 5.418/0.00017

OSBPL1A 1.842 - - 0.958 - 0.884 -

Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740}

Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411}
70. MligTC455_10968 7 0.14 Mlig455_015698

Neo: -

Age: -

HMCN1 1.841 - - 0.860 - 0.981 - Mlig455_015698 {REF} {Length: 1150} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=52.4, Expect=5e-07]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=60.5, Expect=6e-10]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [Score=51.6, Expect=2e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=60.1, Expect=4e-10]} {RNA1310_100476} {RNA815_63742}
71. MligTC455_14795 8 0.16 Mlig455_001604

Neo: -

Age: -

NPR1 1.841 - - 0.860 - 0.981 - Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875}
72. MligTC455_43979 188 3.92 Mlig455_000082, Mlig455_063749

Neo: -

Age: -

GHSR 1.841 - - 0.867 - 0.974 -

Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553}

Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553}
73. MligTC455_44159 80 1.67 Mlig455_019040, Mlig455_055663

Neo: -

Age: Down-Up-Up

ADRB1, GALR3 1.84 - 0.866 - - 0.974 -

Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615}

Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615}
74. MligTC455_19454 11 0.23 Mlig455_034200

Neo: -

Age: -

KREMEN1 1.839 - - 0.862 - 0.977 - Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128}
75. MligTC455_50794 32 0.67 Mlig455_026944, Mlig455_027032, Mlig455_027095

Neo: -

Age: -

1.839 - - 0.884 - 0.955 -

Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317}

Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317}

Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317}
76. MligTC455_21227 18 0.37 Mlig455_018373

Neo: -

Age: -

RGS6 1.838 - - 0.861 - 0.977 - Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067}
77. MligTC455_42580 98 2.04 Mlig455_014929, Mlig455_045199

Neo: -

Age: -

NKX2-2 1.838 - - 0.857 - 0.981 -

Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707}

Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707}
78. MligTC455_47949 48 1 Mlig455_026482, Mlig455_026492

Neo: -

Age: -

CHRNA3 1.838 - - 0.864 - 0.974 -

Mlig455_026482 {REF} {Length: 2240} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657}

Mlig455_026492 {REF} {Length: 1090} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=248.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.1]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=398, Expect=8e-133]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=382, Expect=5e-127]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=382, Expect=2e-126]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=398, Expect=4e-133]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=397, Expect=5e-133]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=384, Expect=1e-127]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=473, Expect=1e-161]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=445, Expect=7e-152]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=416, Expect=2e-140]} {RNA1310_45284} {RNA815_36657}
79. MligTC455_23314 139 2.9 Mlig455_039680

Neo: -

Age: -

CACNA2D2 1.836 - - 0.886 - 0.950 - Mlig455_039680 {REF} {Length: 4498} {Pfam: VWA N-terminal [PF08399.13, score=89.9]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=86.3]; von Willebrand factor type A domain [PF13768.8, score=38.0]; von Willebrand factor type A domain [PF00092.30, score=36.1]; von Willebrand factor type A domain [PF13519.8, score=31.5]; Cache domain [PF02743.20, score=26.9]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [RH, Score=340, Expect=6e-98]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=328, Expect=3e-94]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [RH, Score=338, Expect=1e-97]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=330, Expect=4e-95]} {Dmel: FBgn0028863, CG4587, [RH, Score=234, Expect=2e-62]} {Celegans: WBGene00007041, tag-180, [RH, Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=155, Expect=5e-38]} {RNA1509_48733} {RNA1310_3844, RNA1509_48733} {RNA1509_48733, RNA815_18071}
80. MligTC455_43383 29 0.6 Mlig455_035092

Neo: -

Age: -

1.835 - - 0.876 - 0.959 - Mlig455_035092 {REF} {Length: 654} {NoTransDecoderORF} {RNA1310_42279} {RNA815_20885}
81. MligTC455_49492 10 0.21 Mlig455_054890

Neo: -

Age: -

1.835 - - 0.854 - 0.981 - Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832}
82. MligTC455_18100 17 0.36 Mlig455_069127

Neo: -

Age: -

PPA1 1.834 - - 0.871 - 0.963 - Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340}
83. MligTC455_53720 144 2.99 Mlig455_028516

Neo: -

Age: -

Region-enriched R2: 4.205/0.01762

CTBP2 1.833 - - 0.872 - 0.961 - Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484}
84. MligTC455_35044 248 5.17 Mlig455_037400

Neo: -

Age: Up-Down-Up

Region-enriched R2: 3.538/0.00372

1.83 - - - - 0.956 0.874 Mlig455_037400 {REF} {Length: 2022} {RNA1509_41763} {RNA1310_23070.1, RNA1509_41763} {RNA1509_41763, RNA815_9632}
85. MligTC455_46699 33 0.69 Mlig455_037050

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-0.785

Region-enriched R4: 3.253/0.03515

1.821 - - 0.832 - 0.989 - Mlig455_037050 {REF} {Length: 1266} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=36.8]; NOPS (NUC059) domain [PF08075.13, score=32.2]; YtkA-like [PF13115.8, score=19.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028}
86. MligTC455_09405 6 0.12 Mlig455_069593

Neo: -

Age: -

FCN1 1.819 - - 0.860 - 0.959 - Mlig455_069593 {REF} {Length: 1062} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=116.0]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=111, Expect=5e-28]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000028001, Fga, fibrinogen alpha chain, [Score=100, Expect=4e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=4e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=98.6, Expect=1e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=105, Expect=5e-25]} {Celegans: WBGene00020516, T15B7.1, [Score=62.8, Expect=5e-11]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=44.3, Expect=7e-06]}
87. MligTC455_41543 69 1.43 Mlig455_003996

Neo: -

Age: -

1.818 - - 0.825 - 0.993 - Mlig455_003996 {REF} {Length: 2153} {RNA1310_66245.1}
88. MligTC455_13072 18 0.37 Mlig455_066620

Neo: -

Age: -

HDC 1.817 - - 0.851 - 0.966 - Mlig455_066620 {REF} {Length: 3571} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=359.4]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=26.2]} {Human: ENSG00000140287, HDC, histidine decarboxylase, [RH, Score=493, Expect=1e-167]} {Mouse: ENSMUSG00000027360, Hdc, histidine decarboxylase, [Score=466, Expect=9e-157]} {Dmel: FBgn0005619, Hdc, Histidine decarboxylase, [Score=516, Expect=5e-177]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=404, Expect=8e-133]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=409, Expect=9e-137]} {RNA1310_91546}
89. MligTC455_51759 40 0.83 Mlig455_026782

Neo: -

Age: -

Region-enriched R4: 4.435/0.02831

CNBD2 1.817 - - 0.848 - 0.969 - Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620}
90. MligTC455_16476 126 2.63 Mlig455_042936

Neo: -

Age: -

Region-enriched R2: 3.045/0.04509

1.816 - - 0.854 - 0.962 - Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221}
91. MligTC455_15229 6 0.12 Mlig455_032752

Neo: -

Age: -

1.813 - - 0.832 - 0.981 - Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1}
92. MligTC455_48692 15 0.32 Mlig455_021398

Neo: -

Age: -

Region-enriched R2: 8.096/0.02429

1.813 - 0.838 - - 0.975 - Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005}
93. MligTC455_40340 201 4.19 Mlig455_021026, Mlig455_021062

Neo: -

Age: -

1.811 - - 0.839 - 0.972 -

Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069}

Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069}
94. MligTC455_21258 64 1.34 Mlig455_001143, Mlig455_001305

Neo: -

Age: -

FOXD4 1.808 - - 0.836 - 0.972 -

Mlig455_001143 {REF} {Length: 2344} {Pfam: Forkhead domain [PF00250.20, score=125.5]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [RH, Score=197, Expect=1e-57]; ENSG00000187140, FOXD3, forkhead box D3, [RH, Score=196, Expect=6e-57]} {Mouse: ENSMUSG00000067261, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]; ENSMUSG00000116152, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [RH, Score=210, Expect=8e-63]} {Celegans: WBGene00006853, unc-130, [RH, Score=207, Expect=4e-63]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [RH, Score=223, Expect=2e-68]} {RNA1310_116948}

Mlig455_001305 {REF} {Length: 1757} {Pfam: Forkhead domain [PF00250.20, score=51.7]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [Score=99.4, Expect=3e-22]; ENSG00000187140, FOXD3, forkhead box D3, [Score=96.3, Expect=5e-21]} {Mouse: ENSMUSG00000116152, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]; ENSMUSG00000067261, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [Score=112, Expect=6e-27]} {Celegans: WBGene00006853, unc-130, [Score=115, Expect=7e-29]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [Score=124, Expect=2e-31]} {RNA1310_116948}
95. MligTC455_12404 10 0.2 Mlig455_059246

Neo: -

Age: -

1.806 - - 0.825 - 0.981 - Mlig455_059246 {REF} {Length: 1713} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.7]} {RNA1509_24218} {RNA1310_21248} {RNA815_14520}
96. MligTC455_13434 15 0.3 Mlig455_025922

Neo: -

Age: -

1.806 - - 0.806 - 1.000 - Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338}
97. MligTC455_10018 16 0.32 Mlig455_034726, Mlig455_067577

Neo: -

Age: -

GUCY2D, GUCY2F 1.805 - - 0.825 - 0.980 -

Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442}

Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378}
98. MligTC455_32391 75 1.56 Mlig455_017179, Mlig455_048147

Neo: -

Age: -

SDCBP2 1.804 - - 0.826 - 0.978 -

Mlig455_017179 {REF} {Length: 3606} {Pfam: PDZ domain [PF00595.26, score=88.1]; PDZ domain [PF17820.3, score=72.4]; PDZ domain [PF13180.8, score=47.6]; Immunoglobulin domain [PF13927.8, score=44.1]; Immunoglobulin domain [PF00047.27, score=37.4]; Immunoglobulin V-set domain [PF07686.19, score=35.7]; Immunoglobulin I-set domain [PF07679.18, score=25.6]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=59.3, Expect=2e-09]; ENSG00000006611, USH1C, USH1 protein network component harmonin, [Score=56.6, Expect=2e-07]} {Mouse: ENSMUSG00000038298, Pdzk1, PDZ domain containing 1, [Score=60.1, Expect=8e-09]; ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=60.1, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=59.3, Expect=5e-09]} {Dmel: FBgn0029835, CG5921, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=63.2, Expect=7e-10]} {Smed: dd_Smed_v6_21860_0_1, dd_Smed_v6_21860_0_1, [RH, Score=146, Expect=2e-38]} {RNA1509_22767} {RNA1310_28491} {RNA815_60114}

Mlig455_048147 {REF} {Length: 2119} {Pfam: Immunoglobulin domain [PF13927.8, score=47.4]; Immunoglobulin domain [PF00047.27, score=41.5]; Immunoglobulin V-set domain [PF07686.19, score=40.0]; Immunoglobulin I-set domain [PF07679.18, score=29.2]; Immunoglobulin domain [PF13895.8, score=25.4]} {RNA1509_22767} {RNA1310_34847}
99. MligTC455_13433 11 0.22 Mlig455_025860

Neo: -

Age: -

Region-enriched R2: 6.296/0.01497

1.8 - - 0.806 - 0.994 - Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338}
100. MligTC455_15771 15 0.31 Mlig455_013616

Neo: -

Age: -

1.799 - - 0.817 - 0.982 - Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869}

There are 523 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA